Jindřich Špinar Selected Research

Jindřich Špinar Research Topics

Disease

13	Heart Failure 01/2021 - 12/2012
7	Stroke (Strokes) 01/2021 - 11/2013
6	Myocardial Infarction 01/2021 - 12/2014
5	Hemorrhage 01/2021 - 11/2013
5	Acute Coronary Syndrome 12/2018 - 05/2014
3	Hypertension (High Blood Pressure) 04/2016 - 12/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2015
2	Body Weight (Weight, Body) 01/2022 - 01/2019
2	Diabetes Mellitus 01/2019 - 10/2018
2	Renal Insufficiency (Renal Failure) 01/2019 - 08/2017
2	Left Ventricular Dysfunction 11/2018 - 11/2018
2	Ischemic Stroke 10/2018 - 09/2016
2	Atrial Fibrillation 11/2016 - 11/2013
2	Coronary Disease (Coronary Heart Disease) 09/2016 - 12/2014
1	Obesity 01/2022
1	Hypotension (Low Blood Pressure) 01/2021
1	Syncope (Fainting) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Dyspnea (Shortness of Breath) 01/2019
1	Sudden Death 12/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2018
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 11/2016
1	Hemorrhagic Stroke 09/2016
1	Ischemia 06/2016
1	Peripheral Arterial Disease 06/2016
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 06/2015
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 06/2015
1	Cardiac Arrhythmias (Arrythmia) 04/2015
1	Unstable Angina 12/2014
1	Pulmonary Embolism 05/2014
1	Cardiogenic Shock 02/2014
1	Septic Shock (Toxic Shock Syndrome) 02/2014
1	ST Elevation Myocardial Infarction 02/2014
1	Embolism (Embolus) 11/2013
1	Hyperuricemia 12/2012

Drug/Important Bio-Agent (IBA)

4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 06/2015
4	TicagrelorIBA 01/2021 - 06/2015
4	Natriuretic PeptidesIBA 01/2019 - 05/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2019
2	DiureticsIBA 01/2021 - 11/2016
2	SodiumIBA 01/2021 - 01/2019
2	Ezetimibe (Zetia)FDA Link 10/2018 - 12/2014
2	Simvastatin (Zocor)FDA LinkGeneric 10/2018 - 12/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2018 - 12/2014
2	Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link 10/2018 - 12/2014
2	LDL CholesterolIBA 10/2018 - 12/2014
2	Warfarin (Coumadin)FDA LinkGeneric 08/2017 - 11/2013
2	Amlodipine (Norvasc)FDA LinkGeneric 04/2016 - 05/2015
1	dapagliflozinIBA 01/2022
1	vericiguatIBA 01/2021
1	empagliflozinIBA 01/2021
1	Soluble Guanylyl CyclaseIBA 01/2021
1	SymportersIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 12/2018
1	Lipocalin-2IBA 01/2018
1	RivaroxabanIBA 08/2017
1	Angiotensin II Type 1 Receptor BlockersIBA 11/2016
1	Digoxin (Digitek)FDA LinkGeneric 11/2016
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2016
1	pro-brain natriuretic peptide (1-76)IBA 11/2016
1	omega-Chloroacetophenone (Mace)IBA 06/2016
1	candesartanIBA 04/2016
1	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2015
1	Purinergic P2Y Receptor AntagonistsIBA 06/2015
1	Valsartan (Vals)FDA Link 05/2015
1	Neprilysin (Neutral Endopeptidase)IBA 05/2015
1	AngiotensinsIBA 05/2015
1	ReninIBA 05/2015
1	aliskiren FDA Link 05/2015
1	Indapamide FDA LinkGeneric 05/2015
1	Perindopril FDA LinkGeneric 05/2015
1	Enalapril FDA LinkGeneric 05/2015
1	sacubitril and valsartan sodium hydrate drug combinationIBA 05/2015
1	Anti-Arrhythmia AgentsIBA 04/2015
1	Pharmaceutical PreparationsIBA 12/2014
1	CholesterolIBA 12/2014
1	oxidized low density lipoproteinIBA 12/2014
1	CytokinesIBA 02/2014
1	Interleukin-6 (Interleukin 6)IBA 02/2014
1	edoxabanIBA 11/2013
1	Allopurinol (Remid)FDA LinkGeneric 12/2012
1	Uric Acid (Urate)IBA 12/2012

Therapy/Procedure

12	Therapeutics 01/2021 - 12/2012
4	Secondary Prevention 10/2018 - 06/2015
2	Patient Readmission 01/2019 - 12/2014
1	Stents 01/2021
1	Intravenous Infusions 01/2019
1	Length of Stay 01/2019
1	Heart Transplantation (Grafting, Heart) 11/2018
1	Cardiopulmonary Resuscitation (CPR) 06/2015
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 06/2015
1	Catheters 04/2014